While inappropriately restricting insulin has been extensively investigated for its association with poorer health in individuals with T1DM, less has been researched on the insulin-treated counterparts of T2DM, where they need insulin injections as their primary treatment because they fail to reach their glycemic goal with other hypoglycemic medications [11–13]. The gene discussed is INS; the disease is type 2 diabetes mellitus.